Managing cardiorenal syndrome in the context of heart failure
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
- ESC Congress 2024
Effects of empagliflozin on cardiac remodeling post-MI
Jaclyn Carberry, MD
- ESC Congress 2024
Beneficial effects of MRAs in HF across the LVEF spectrum
Pardeep Jhund, MD, PhD
- ESC Congress 2024
Effects of empaglifozin on kidney outcomes after acute MI
Deepak Bhatt, MD
- ESC Congress 2024
In patients with HFmrEF/HFpEF, finerenone reduces composite of CV death or total HF events
Scott Solomon, MD